基本信息
浏览量:0
职业迁徙
个人简介
1: Gomes SIL, Guimarães B, Gasco P, Blosi M, Costa AL, Scott-Fordsmand JJ,
Amorim MJB. Nanoemulsion carriers for drug delivery: Assessment of environmental
hazards. Environ Pollut. 2023 Apr 18;328:121669. doi:
10.1016/j.envpol.2023.121669. Epub ahead of print. PMID: 37080512.
2: González-Fernández FM, Delledonne A, Nicoli S, Gasco P, Padula C, Santi P,
Sissa C, Pescina S. Nanostructured Lipid Carriers for Enhanced Transscleral
Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and
Multiphoton Microscopy Studies. Pharmaceutics. 2023 Jan 25;15(2):407. doi:
10.3390/pharmaceutics15020407. PMID: 36839729; PMCID: PMC9961953.
3: Antonello G, Marucco A, Gazzano E, Kainourgios P, Ravagli C, Gonzalez-Paredes
A, Sprio S, Padín-González E, Soliman MG, Beal D, Barbero F, Gasco P, Baldi G,
Carriere M, Monopoli MP, Charitidis CA, Bergamaschi E, Fenoglio I, Riganti C.
Changes of physico-chemical properties of nano-biomaterials by digestion fluids
affect the physiological properties of epithelial intestinal cells and barrier
models. Part Fibre Toxicol. 2022 Jul 19;19(1):49. doi:
10.1186/s12989-022-00491-w. PMID: 35854319; PMCID: PMC9297619.
4: Padín-González E, Lancaster P, Bottini M, Gasco P, Tran L, Fadeel B, Wilkins
T, Monopoli MP. Understanding the Role and Impact of Poly (Ethylene Glycol)
(PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines. Front
Bioeng Biotechnol. 2022 Jun 7;10:882363. doi: 10.3389/fbioe.2022.882363. PMID:
35747492; PMCID: PMC9209764.
5: Chinigò G, Gonzalez-Paredes A, Gilardino A, Barbero N, Barolo C, Gasco P,
Fiorio Pla A, Visentin S. Polymethine dyes-loaded solid lipid nanoparticles
(SLN) as promising photosensitizers for biomedical applications. Spectrochim
Acta A Mol Biomol Spectrosc. 2022 Apr 15;271:120909. doi:
10.1016/j.saa.2022.120909. Epub 2022 Jan 19. PMID: 35093822.
6: González-Fernández FM, Bianchera A, Gasco P, Nicoli S, Pescina S. Lipid-Based
Nanocarriers for Ophthalmic Administration: Towards Experimental Design
Implementation. Pharmaceutics. 2021 Mar 26;13(4):447. doi:
10.3390/pharmaceutics13040447. PMID: 33810399; PMCID: PMC8067198.
7: Mistraletti G, Paroni R, Umbrello M, Moro Salihovic B, Coppola S, Froio S,
Finati E, Gasco P, Savoca A, Manca D, Chiumello D, Reiter RJ, Iapichino G.
Different routes and formulations of melatonin in critically ill patients. A
pharmacokinetic randomized study. Clin Endocrinol (Oxf). 2019 Jul;91(1):209-218.
doi: 10.1111/cen.13993. Epub 2019 Apr 30. PMID: 31004517.
8: González-Paredes A, Sitia L, Ruyra A, Morris CJ, Wheeler GN, McArthur M,
Gasco P. Solid lipid nanoparticles for the delivery of anti-microbial
oligonucleotides. Eur J Pharm Biopharm. 2019 Jan;134:166-177. doi:
10.1016/j.ejpb.2018.11.017. Epub 2018 Nov 20. PMID: 30468838.
9: Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa
C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory
drugs to treat inflammatory bowel disease: Effects in an in vivo model.
World J Gastroenterol. 2017 Jun 21;23(23):4200-4210. doi:
10.3748/wjg.v23.i23.4200. PMID: 28694660; PMCID: PMC5483494.
10: Dal Magro R, Ornaghi F, Cambianica I, Beretta S, Re F, Musicanti C, Rigolio
R, Donzelli E, Canta A, Ballarini E, Cavaletti G, Gasco P, Sancini G. ApoE-
modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain
barrier. J Control Release. 2017 Mar 10;249:103-110. doi:
10.1016/j.jconrel.2017.01.039. Epub 2017 Jan 31. PMID: 28153761.
11: Reforgiato MR, Milano G, Fabriàs G, Casas J, Gasco P, Paroni R, Samaja M,
Ghidoni R, Caretti A, Signorelli P. Inhibition of ceramide de novo synthesis as
a postischemic strategy to reduce myocardial reperfusion injury. Basic Res
Cardiol. 2016 Mar;111(2):12. doi: 10.1007/s00395-016-0533-x. Epub 2016 Jan 19.
PMID: 26786259.
12: Perdoni F, Signorelli P, Cirasola D, Caretti A, Galimberti V, Biggiogera M,
Gasco P, Musicanti C, Morace G, Borghi E. Antifungal activity of Myriocin on
clinically relevant Aspergillus fumigatus strains producing biofilm. BMC
Microbiol. 2015 Oct 30;15:248. doi: 10.1186/s12866-015-0588-0. PMID: 26519193;
PMCID: PMC4628231.
13: Foglietta F, Serpe L, Canaparo R, Vivenza N, Riccio G, Imbalzano E, Gasco P,
Zara GP. Modulation of butyrate anticancer activity by solid lipid nanoparticle
delivery: an in vitro investigation on human breast cancer and leukemia cell
lines. J Pharm Pharm Sci. 2014;17(2):231-47. doi: 10.18433/j3xp4r. PMID:
24934552.
14: Caretti A, Bragonzi A, Facchini M, De Fino I, Riva C, Gasco P, Musicanti C,
Casas J, Fabriàs G, Ghidoni R, Signorelli P. Anti-inflammatory action of lipid
nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
Biochim Biophys Acta. 2014 Jan;1840(1):586-94. doi:
10.1016/j.bbagen.2013.10.018. Epub 2013 Oct 18. PMID: 24141140; PMCID:
PMC4097882.
15: Minelli R, Occhipinti S, Gigliotti CL, Barrera G, Gasco P, Conti L,
Chiocchetti A, Zara GP, Fantozzi R, Giovarelli M, Dianzani U, Dianzani C. Sol
研究兴趣
论文作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
作者统计
#Papers: 0
#Citation: 0
H-Index: 0
G-Index: 0
Sociability: 0
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn